View links to journals and guidelines used in the resource

Bow, E. J. (1998). Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 1–5.

British Committee for Standards in Haematology Guideline Up-date. (2001). The prevention and treatment of infection in patients with an absent or dysfunctional spleen. [Online]. Available at: http://www.bcshguidelines.com/pdf/SPLEEN96.pdf.

Centres for Disease Control and Prevention, U.S. Department of Health and Human Services. (2002). Epidemiology and Prevention of Vaccine-Related DiseasesSeventh Edition. Appendix A. [Online]. Available at: http://www.cdc.gov/nip/publications/pink/#download.

Evans, K. L. (1994). Fortnightly review: diagnosis and management of sinusitis. British Medical Journal 309, 1415–22.

Finch, F. G. (2000). Infection in immunocompromised patients. In: Antimicrobial Chemotherapy, 4th edn. (Greenwood, D., Ed), pp. 335–45. Oxford University Press, Oxford.

Golden, S. H., Peart-Vigilance, C., Kao, L. & Brancati, F. L. (1999). Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22, Suppl. 9, 1408–14.

Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R. et al. (1997). 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clinical Infectious Diseases 25, Suppl. 3, 551–73.

Joint Tuberculosis Committee of the British Thoracic Society. (2000). Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 55, Suppl. 11, 887–901. [Online]. Available at: http://www.brit-thoracic.org.uk/pdf/TB.pdf.

Klastersky, J. (1998). Science and pragmatism in the treatment and prevention of neutropenic infection. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 13–24.

Mulinde, J. & Joshi, M. (1998). The diagnostic and therapeutic approach to lower respiratory tract infections in the neutropenic patient. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 51–5.

Oppenheim, B. A. (1998). The changing pattern of infection in neutropenic patients. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 7–11.

Pinner, R. W., Hajjeh, R. A. & Powderly, W. G. (1995). Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clinical Infectious Disease Reports 21, Suppl. 1, S103–7.

Pizzo, P., A. (1999). Fever in immunocompromised patients. New England Journal of Medicine 341, Suppl. 12, 873–900.

Rubin, R., H. (2001). Cytomegalovirus in solid organ transplantation. Transplant Infectious Disease 3, Suppl. 2, 1–5.

Ruoppi, P., Dietz A., Nikanne, E., Seppa, J., Markkanen, H. & Nuutinen, J. (2001). Paranasal sinus mucormycosis: a report of two cases. Acta Oto-laryngologica 121, Suppl. 8, 948–52.

Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G. et al. for the Mycoses Study Group Cryptococcal Subproject. (2000). Practice Guidelines for the Management of Cryptococcal Disease. Clinical Infectious Diseases 30, Suppl. 4, 710–8.

Samadi, D. S., Goldberg, A. N. & Orlandi, R. R. (2001). Granulocyte transfusion in the management of fulminant invasive fungal rhinosinusitis. American Journal of Rhinology 15, Suppl. 4, 263–5.

Singh, N. (2000). Infections in solid organ transplant recipients. Current Opinion in Infectious Diseases 13, Suppl. 4, 343–7.

Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S., Denning, D. W. et al. (2000). Practice guidelines for diseases caused by Aspergillus. Clinical Infectious Diseases 30, Suppl. 4, 696–709.

Sub-committee of the Joint Tuberculosis Committee of the British Thoracic Society. (1992). Guidelines on the management of tuberculosis and HIV infection in the United Kingdom. British Medical Journal, 304, 1231–3.

The Interdepartmental Working Group on Tuberculosis. (1998). The prevention and control of tuberculosis in the United Kingdom. Department of Health. [Online]. Available at: http://www.doh.gov.uk/pub/docs/doh/tbuk.pdf.

Viscoli, C. (1998). The evolution of the empirical management of fever and neutropenia in cancer patients. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 65–80.

Warnock, D. W. (1998). Fungal infections in neutropenia: current problems and chemotherapeutic control. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 95–105.

Wood, M. J. (1998). Viral infections in neutropenia: current problems and chemotherapeutic control. Journal of Antimicrobial Chemotherapy 41, Suppl. D, 81–93.

Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. (1996). Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. British Medical Journal 312, Suppl. 7028, 430–4. [Online]. Available at: http://bmj.com/cgi/content/full/312/7028/430.